ADMA Biologics share price logo

ADMA Biologics

NASDAQ: ADMA

Mid Cap

$9.84

+0.08

(+0.82%)

as on

ADMA Biologics Stock Performance

as on August 22, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $9.68
    $9.95
    downward going graph

    1.63%

    Downside

    1.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.21
    $20.46
    downward going graph

    26.73%

    Downside

    107.91%

    Upside

    downward going graph

ADMA Biologics share price movements today

Previous Close
$9.76
Open
$9.78
Volume
1.2M
Market Cap
$2.1B
Day's Low - High
$9.68 - $9.95
52 Week Low - High
$7.21 - $20.46

ADMA Biologics Historical Returns

1 Month Return
+ 8.73 %
3 Month Return
+ 14.51 %
1 Year Return
-44.26 %
3 Year Return
+ 120.75 %
5 Year Return
+ 612.03 %

ADMA Biologics Stock Fundamentals & Key Indicators

Check ADMA Biologics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

0.7967

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.53%

PE Ratio (TTM)

13.53

Industry PE ratio

-13.046547619047619

PEG Ratio

0

EBITDA

224.2M

Revenue (TTM)

512.3M

Profit Margin

32.98%

Return On Equity TTM

41.90%

ADMA Biologics Stock Valuation

Track how ADMA Biologics P/E has moved over time to understand its valuation trends.

ADMA Biologics in the last 5 years

  • Overview

  • Trends

Lowest (-38.49x)

September 30, 2023

Industry (-13.05x)

August 17, 2026

Today (13.53x)

August 17, 2026

Highest (49.69x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 13.53x

ADMA Biologics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ADMA Biologics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.1B612.03%13.5332.98%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for ADMA Biologics Stock including INR - Dollar returns

The ADMA Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

ADMA Biologics investment value today

Current value as on today

₹63,473

Returns

-₹36,527

(-36.53%)

Returns from ADMA Biologics Stock

-₹42,084 (-42.08%)

Dollar Impact

₹5,557 (+5.56%)

Analyst Recommendation on ADMA Biologics Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for ADMA Biologics. Average target price of $17

ADMA Biologics Share Price Target

Get share price movements and forecasts by analysts on ADMA Biologics.

What analysts predicted

42.12%UPSIDE

Target Price

$17

Current Price

$9.84

Analyzed by

4 Analysts

Target

$17.00

ADMA Biologics target price $17, a slight upside of 42.12% compared to current price of $9.84. According to 4 analysts rating.

Indian Investors' Interest in ADMA Biologics Stock

Search interest for ADMA Biologics Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:24% versus previous 30 day period

ADMA Biologics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
81
107
119
117
114
121
134
139
114
124
Gross Profit
39
57
59
63
61
67
75
88
80
86
Operating Income
21
39
39
38
34
42
51
62
50
52
EBITDA
24
41
42
39
37
43
51
65
61
57
Interest Expense
3
3
3
2
1
1
1
1
2
3
Depreciation
2
2
1
1
1
2
2
2
1
1
Income Before Tax
18
35
36
34
33
40
47
61
57
50
Income Tax Expense
0
3
0
-77
6
5
11
12
11
12
Net Income
17
32
35
111
26
34
36
49
45
37
Net Profit Margin
21.75%
29.91%
29.96%
95.19%
23.44%
28.05%
27.14%
35.48%
39.59%
30.40%

ADMA Biologics Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
22
16
29
42
80
154
258
426
510
Gross Profit
4
-6
-25
-10
-19
1
35
88
219
292
Operating Income
-17
-39
-60
-41
-64
-58
-39
21
138
191
EBITDA
-16
-39
-56
-36
-59
-53
-39
5
147
197
Interest Expense
2
3
5
8
11
13
19
25
13
7
Depreciation
-
2
3
3
3
5
7
8
8
8
Income Before Tax
-19
-43
-65
-48
-75
-71
-65
-28
125
182
Income Tax Expense
2
4
5
8
11
12
19
8
-71
35
Net Income
-19
-43
-65
-48
-75
-71
-65
-28
197
146
Net Profit Margin
-183.05%
-192.26%
-387.06%
-164.50%
-179.41%
-88.52%
-42.77%
-10.94%
46.35%
28.80%

ADMA Biologics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
32
35
111
26
34
36
49
45
37
Operating Cash Flow
45
25
50
-19
21
13
35
58
29
Investing Cash Flow
-2
-1
-2
-4
-2
-14
0
2
-2
Financing Cash Flow
0
-25
-31
-7
0
-27
-9
-10
-29
Change in Cash
42
-1
16
-31
18
-28
26
50
-2

ADMA Biologics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-43
-65
-48
-75
-71
-65
-28
197
146
Operating Cash Flow
-37
-62
-76
-102
-112
-59
8
118
50
Investing Cash Flow
15
-2
-3
-12
-13
-13
-4
-8
-21
Financing Cash Flow
60
42
80
143
121
108
-38
-58
-44
Change in Cash
38
-21
0
29
-4
35
-35
51
-15

Mutual Funds that own ADMA Biologics Stock

Check out the Mutual Funds with significant holdings in ADMA Biologics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.240368%
13977470
SMALLCAP World Fund Inc
4.411013%
9879994
TIAA-CREF Funds
1.857902%
4161416
American Century Mutual Funds, Inc.
1.50183%
3363870
Fidelity Salem Street Trust
1.118479%
2505222

Global Institutional Holdings in ADMA Biologics

Funds
Holdings
iShares
12.4%
Vanguard
7.62%
SPDR
5.46%
First Trust
4.46%
Xtrackers
1.11%

ADMA Biologics News & Key Events

  • img

    Today's Timeline - 24 March

    Tue, 08:01 PM

    -

    ADMA Biologics' 2026 EPS estimates increased from 85 cents to 96 cents, but shares have lost 11.3% over six months.

Insights on ADMA Biologics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 114.49M → 124.39M (in $), with an average increase of 8.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ADMA stock has moved up by 3.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 510.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 570.7% return, outperforming this stock by 424.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 49.37M → 37.82M (in $), with an average decrease of 12.4% per quarter

About ADMA Biologics

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
OrganisationADMA Biologics
Headquarters465 State Route 17, Ramsey, NJ, United States, 07446
IndustryBiotechnology
CEOMr. Adam S. Grossman
E-voting on sharesClick here to vote

Key Management of ADMA Biologics

Name

Title

Mr. John Hafl

Executive Director of Sales

Mr. Skyler Bloom

Senior Director of Business Development & Corporate Strategy

Mr. Adam S. Grossman

Co-Founder, President, CEO & Director

Dr. Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

Mr. P. Terence Kohler

CFO & Treasurer

Ms. Kaitlin M. Kestenberg

COO & Senior VP of Compliance

Mr. Michael Goldstein

General Counsel

FAQs

What is ADMA Biologics share price today?

ADMA Biologics share price today is $9.84 as on at the close of the market. ADMA Biologics share today touched a day high of $9.95 and a low of $9.68.

What is the 52 week high and 52 week low for ADMA Biologics share?

ADMA Biologics share touched a 52 week high of $20.46 on and a 52 week low of $7.21 on . ADMA Biologics stock price today i.e. is closed at $9.84,which is 51.90% down from its 52 week high and 36.48% up from its 52 week low.

What is ADMA Biologics's market capitalisation today?

ADMA Biologics market capitalisation is $0.00T as on .

How to invest in ADMA Biologics Stock (ADMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ADMA Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ADMA Biologics Shares that will get you 0.1524 shares as per ADMA Biologics share price of $9.84 per share as on August 22, 2026 at 8:45 am IST.

What is the minimum amount required to buy ADMA Biologics Stock (ADMA) from India?

Indian investors can start investing in ADMA Biologics (ADMA) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in ADMA Biologics stock (as per the Rupee-Dollar exchange rate as on ). Based on ADMA Biologics share’s latest price of $9.84 as on August 22, 2026 at 8:45 am IST, you will get 1.0163 shares of ADMA Biologics. Learn more about fractional shares .

What are the returns that ADMA Biologics has given to Indian investors in the last 5 years?

ADMA Biologics stock has given 612.03% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?